Delphinidin treatment of EGFR overexpressing NSCLC cells also significantly reduced phosphorylation of MAPKs such as ERK1/2, JNK1/2 and p38 (Figure 2A). The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.